45
Axelyf, Inc. raises $4.8M under Reg D
Company raise · Raising · Offering $6.3M · Sold $4.8M · CHESTNUT HILL, MA · filed 2025-08-07
40
Axelyf raises $2.63M in biotech funding round under Reg D 506(b)
Company raise · Raising · CHESTNUT HILL, MA · Form D filed 2026-10-13
Axelyf, Inc., a Delaware biotech corporation incorporated in 2025, has raised $2.63M of a $2.7M offering in Chestnut Hill, MA. The company closed its first sale on October 7, 2026, with 8 investors and $69K remaining in the round.
Note: Company incorporated in 2025; first sale occurred October 7, 2026, just 6 days before filing. Offering nearly fully committed with only $69K remaining.
operating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Orn Almarsson | Executive Officer, Director, Promoter |
| Leslie Williams | Director |
| Arni Blondal | Director |
Signed by Orn Almarsson, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.